# CUBIST PHARMACEUTICALS INC

CUBIST PHARMACEUTICALS INC is a company headquartered in Lexington, MA, United States.

## Company overview

- **Legal name:** CUBIST PHARMACEUTICALS INC
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Lexington, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0000912183

## About

CUBIST PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000912183, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2014-02-25, it reported annual revenue of USD 1,054,442,000; total assets of USD 3,145,821,000 for the fiscal period ended 2013-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2013 (period ended 2013-12-31)

- **Revenue:** $1.1B (USD 1,054,442,000)
- **Total assets:** $3.1B (USD 3,145,821,000)
- **Cash and equivalents:** $91.1M (USD 91,058,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2012 (period ended 2012-12-31)

- **Revenue:** $926.4M (USD 926,359,000)
- **Total assets:** $1.9B (USD 1,932,385,000)
- **Cash and equivalents:** $104.0M (USD 104,041,000)

### FY2011 (period ended 2011-12-31)

- **Revenue:** $754.0M (USD 753,972,000)
- **Total assets:** $1.9B (USD 1,887,455,000)
- **Cash and equivalents:** $197.6M (USD 197,618,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2010 (period ended 2010-12-31)

- **Revenue:** $636.5M (USD 636,458,000)
- **Total assets:** $1.4B (USD 1,415,157,000)
- **Cash and equivalents:** $373.0M (USD 372,969,000)
- **Operating cash flow:** $184.5M (USD 184,474,000)

## Recent SEC filings

- Form SC 13G — filed 2015-02-17
- Form 8-K — filed 2015-01-21 — period 2015-01-21 — 8-K
- Form 8-K — filed 2015-01-13 — period 2015-01-13 — 8-K
- Form 8-K — filed 2015-01-02 — period 2015-01-01 — 8-K
- Form 8-K — filed 2014-12-22 — period 2014-12-19 — 8-K
- Form 8-K — filed 2014-12-19 — period 2014-12-19 — 8-K
- Form 8-K — filed 2014-12-09 — period 2014-12-08 — 8-K
- Form 8-K — filed 2014-12-08 — period 2014-12-07 — 8-K
- Form 10-Q — filed 2014-11-07 — period 2014-09-30 — 10-Q
- Form 8-K — filed 2014-11-06 — period 2014-11-05 — 8-K
- Form 8-K — filed 2014-10-22 — period 2014-10-20 — 8-K
- Form 8-K — filed 2014-10-21 — period 2014-10-21 — 8-K

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/cubist-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology